Alnylam Pharmaceuticals | Crediti Commerciali



Trade Debtors Cambiamento Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 4.11M 991K 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Amgen USD 6.78B 535M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Incyte USD 823.13M 30.02M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 7.56B 594M 2024-12
PTC Therapeutics USD 158.55M 41.42M 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Sanofi 10.63B 1.82B 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Takeda JPY 735.06B 14.01B 2024-12
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12
Xencor USD 60.85M 50.64M 2024-12



Alnylam Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.